ADHD 360 is the UK’s largest virtual healthcare service specializing in ADHD diagnosis and treatment. Its primary goal…
Blog
Blog
What does the gold standard of ADHD diagnosis and treatment look like in 2025 and beyond?
In 2025, the gold standard of ADHD diagnosis and treatment is evolving, shaped by updated DSM-5 criteria, new…
CHIRP model’s objective technology (QbCheck) improves ADHD care efficiency in New Zealand (2023)
QbCheck’s objective ADHD testing solutions land in New Zealand. The CHIRP model (combining paediatrics, child development services and…
QbCheck as an objective measure of ADHD symptoms to ensure optimal medical treatment in a pediatric(0-17y) population (2023)
The CHIRP model (combining paediatrics, child development services and child and adolescent mental health) came into effect in…
Medical research study on QbCheck’s efficacy to monitor treatment effects (2025)
The present study aims to evaluate the effectiveness of ADHD treatment and the utility of QbCheck in…
Accelerating ADHD treatment with QbCheck: How one patient found answers in weeks, instead of years
Access to comprehensive ADHD testing and follow-up treatment management is limited with traditional models involving months of waiting,…
ADHD vs Autism in clinic settings: red flags and co-diagnosis tips
More than half of adults with ADHD also live with another mental health condition, and almost 40%…
The new gold standard in ADHD medication management: Titration guided by objective data
Want to understand the correlation between titration and objective data? Watch the full episode below. Want episodes like…
Understanding ADHD in 2025: Prevalence, diagnosis, guidance, and treatment
Our understanding of ADHD, the symptoms, treatment options, and assessment methodologies, is evolving rapidly. In a short time,…
How objective ADHD technology is reducing uncertainty and creating efficiency
ADHD is one of the most prevalent neurodevelopmental disorders, but access to timely and efficient treatment continues to…
